Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Leuk Lymphoma. 2015 Dec 24;57(8):1969–1973. doi: 10.3109/10428194.2015.1122785

Table 1. Summary of mutations over disease course.

Name of Mutation Initial BM (Only PV) PV transformation to AML PV alone (AML in Remission)
JAK2-V617F Not Done Positive Positive
FLT3 Not Done Negative Negative
IDH1, IDH2 Not Done Negative Negative
KIT Not Done Negative Negative
KRAS, NRAS Not Done Negative Negative
NPM1 Not Done Negative Negative
DNMT3A Not Done Not Done Positive
TET2 Not Done Not Done Positive

Miscellaneous other mutations were tested in the bone marrow in remission for AML with presence of PV and were negative - ABL1, ASXL1, BRAF, EGFR, EZH2, FLT3, GATA1, GATA2, HRAS, IDH1, IDH2, IKZF2, KIT, KRAS, MDM2, MLL, MPL, MYD88, NOTCH1, NPM1, NRAS, PTPN11, RUNX1, TP53 and WT1 were not detected.